<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sinclair, Heather Q.</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Halperin, Jonathan L.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Peripheral Vascular Disease and Dilated Aorta</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-02-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">16-16</style></pages><abstract><style  face="normal" font="default" size="100%">Peripheral arterial disease (PAD) affects more than 8 million adults in the United States, many of whom have one or more coinciding cardiovascular disease risk factors [D Lloyd-Jones. Circulation 2010]. It is associated with high mortality rates, poor outcomes, and is often undetected due to a lack of symptoms [Mukherjee D et al. Am J Cardiol 2007; Saw J et al. J Am Coll Cardiol 2006; Aboyans V et al. J Am Coll Cardiol 2005]. This article discusses prognostic and management strategies for this prevalent disease, as well as recent data concerning thoracic aortic aneurysm and various treatment approaches.</style></abstract><number><style face="normal" font="default" size="100%">6</style></number><volume><style face="normal" font="default" size="100%">9</style></volume></record></records></xml>